Multi-Cancer Early Detection (MCED) is an advanced genomic blood test that screens for a wide range of cancers from a single blood sample. The test detects Circulating Tumour DNA (ctDNA)—tiny fragments of DNA released by tumour cells into the bloodstream. By analysing these tumour-derived DNA fragments, the test can identify potential cancer signals at an early stage.
Limited Time Promotion 50% off, until December 2026
MCED 20 main cancer categories
(including 113 Types of Cancer)
Also Available:
Patient Support Programme (PSP)
Eligible patients may be entitled to up to RM2,000 support for confirmatory imaging and endoscopy following a positive MCED result.
Screens for 20 main cancer categories, including 113 types of cancer.
Advanced genomic analysis to detect cancer signals early.
Simple blood test with no surgery or hospital admission required.
Results available within 21 working days.
